Prohibition Partners
Home / Reports & Data / The Impact Series: Disrupting Petcare
ReportGlobal

The Impact Series: Disrupting Petcare

Disrupting Petcare provides an overview of some of the key developments taking place in the emerging CBD pet supplement market.

  • Analyst-written market analysis
  • PDF + data
  • Published 2021

Cited in boardrooms, legal proceedings & government briefings since 2017. Our figures are built to be defended — sourced, modelled and signed off by PP’s analysts.

Trusted by teams at

DIAGEOKPMGBarclaysNovartisBloomberg

About this edition

Disrupting Petcare provides an overview of some of the key developments taking place in the emerging CBD pet supplement market. It combines PP’s proprietary market sizing with regulatory analysis, giving investors and corporates a single, citable reference — delivered digitally, licensed for internal use, and backed by the analysts who built the numbers.

PDF + data

delivery format

2021

published

Inside this edition

Key findings3
  • Prohibition Partners projects global sales of CBD petcare products to reach US$424.4 million by 2024, representing a compound annual growth rate (CAGR) of 18.6%.
  • The North American market currently hasthe highest rate of pet CBD purchasers and returners with 22% of pet owners having already bought CBD products in the last 12 months.
  • Over half (64%) of pet CBD purchasers are in the 25-35 and 35-44 age brackets.

Who it’s for

Investors & analysts

Defensible sizing and forecasts to underwrite the thesis.

Corporate strategy & FMCG

Opportunity sizing and entry routes across key markets.

More from the library

All research